Surprisingly, KCTD12 expression levels are, in these samples, significantly higher in healthy subjects than in both B-ALL and T-ALL subjects, rendering this protein unusable as a potential disease biomarker (Figure 3C). This evidence concerns the gene KCTD12 and acute lymphoblastic leukemia.